nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—Dactinomycin—testicular cancer	0.124	0.193	CbGbCtD
Ticagrelor—CYP3A4—Ifosfamide—testicular cancer	0.0879	0.137	CbGbCtD
Ticagrelor—ABCB1—Vinblastine—testicular cancer	0.0778	0.121	CbGbCtD
Ticagrelor—ABCB1—Cisplatin—testicular cancer	0.0714	0.111	CbGbCtD
Ticagrelor—ABCB1—Etoposide—testicular cancer	0.0701	0.109	CbGbCtD
Ticagrelor—ABCB1—Doxorubicin—testicular cancer	0.0478	0.0744	CbGbCtD
Ticagrelor—CYP3A4—Vinblastine—testicular cancer	0.0466	0.0725	CbGbCtD
Ticagrelor—ABCB1—Methotrexate—testicular cancer	0.0463	0.0721	CbGbCtD
Ticagrelor—CYP3A4—Etoposide—testicular cancer	0.042	0.0654	CbGbCtD
Ticagrelor—CYP3A4—Doxorubicin—testicular cancer	0.0287	0.0446	CbGbCtD
Ticagrelor—Immune system disorder—Etoposide—testicular cancer	0.000792	0.00222	CcSEcCtD
Ticagrelor—Mediastinal disorder—Etoposide—testicular cancer	0.00079	0.00221	CcSEcCtD
Ticagrelor—Asthenia—Vinblastine—testicular cancer	0.000784	0.00219	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Epirubicin—testicular cancer	0.000783	0.00219	CcSEcCtD
Ticagrelor—Nervous system disorder—Ifosfamide—testicular cancer	0.000773	0.00216	CcSEcCtD
Ticagrelor—Renal failure acute—Epirubicin—testicular cancer	0.000769	0.00215	CcSEcCtD
Ticagrelor—Skin disorder—Ifosfamide—testicular cancer	0.000766	0.00214	CcSEcCtD
Ticagrelor—Feeling abnormal—Bleomycin—testicular cancer	0.00076	0.00213	CcSEcCtD
Ticagrelor—Vomiting—Chlorambucil—testicular cancer	0.000758	0.00212	CcSEcCtD
Ticagrelor—Diarrhoea—Vinblastine—testicular cancer	0.000747	0.00209	CcSEcCtD
Ticagrelor—Fatigue—Dactinomycin—testicular cancer	0.000742	0.00208	CcSEcCtD
Ticagrelor—Back pain—Etoposide—testicular cancer	0.000738	0.00207	CcSEcCtD
Ticagrelor—Hypotension—Ifosfamide—testicular cancer	0.000737	0.00206	CcSEcCtD
Ticagrelor—Body temperature increased—Bleomycin—testicular cancer	0.000729	0.00204	CcSEcCtD
Ticagrelor—Cardiac failure—Epirubicin—testicular cancer	0.000728	0.00204	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Doxorubicin—testicular cancer	0.000724	0.00203	CcSEcCtD
Ticagrelor—Dizziness—Vinblastine—testicular cancer	0.000722	0.00202	CcSEcCtD
Ticagrelor—Renal failure acute—Doxorubicin—testicular cancer	0.000712	0.00199	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.00071	0.00199	CcSEcCtD
Ticagrelor—Feeling abnormal—Dactinomycin—testicular cancer	0.000709	0.00199	CcSEcCtD
Ticagrelor—Nausea—Chlorambucil—testicular cancer	0.000708	0.00198	CcSEcCtD
Ticagrelor—Paraesthesia—Ifosfamide—testicular cancer	0.000708	0.00198	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000704	0.00197	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000703	0.00197	CcSEcCtD
Ticagrelor—Dyspnoea—Ifosfamide—testicular cancer	0.000703	0.00197	CcSEcCtD
Ticagrelor—Vomiting—Vinblastine—testicular cancer	0.000694	0.00194	CcSEcCtD
Ticagrelor—Breast disorder—Methotrexate—testicular cancer	0.000686	0.00192	CcSEcCtD
Ticagrelor—Vertigo—Etoposide—testicular cancer	0.000685	0.00192	CcSEcCtD
Ticagrelor—Headache—Vinblastine—testicular cancer	0.000684	0.00192	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000681	0.00191	CcSEcCtD
Ticagrelor—Body temperature increased—Dactinomycin—testicular cancer	0.00068	0.0019	CcSEcCtD
Ticagrelor—Abdominal pain—Dactinomycin—testicular cancer	0.00068	0.0019	CcSEcCtD
Ticagrelor—Fatigue—Ifosfamide—testicular cancer	0.00068	0.0019	CcSEcCtD
Ticagrelor—Hypersensitivity—Bleomycin—testicular cancer	0.00068	0.0019	CcSEcCtD
Ticagrelor—Constipation—Ifosfamide—testicular cancer	0.000674	0.00189	CcSEcCtD
Ticagrelor—Cardiac failure—Doxorubicin—testicular cancer	0.000673	0.00189	CcSEcCtD
Ticagrelor—Loss of consciousness—Etoposide—testicular cancer	0.00067	0.00188	CcSEcCtD
Ticagrelor—Nervous system disorder—Cisplatin—testicular cancer	0.000666	0.00187	CcSEcCtD
Ticagrelor—Cough—Etoposide—testicular cancer	0.000666	0.00186	CcSEcCtD
Ticagrelor—Blood creatinine increased—Epirubicin—testicular cancer	0.000665	0.00186	CcSEcCtD
Ticagrelor—Asthenia—Bleomycin—testicular cancer	0.000662	0.00185	CcSEcCtD
Ticagrelor—Skin disorder—Cisplatin—testicular cancer	0.00066	0.00185	CcSEcCtD
Ticagrelor—Hypertension—Etoposide—testicular cancer	0.000659	0.00184	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.000657	0.00184	CcSEcCtD
Ticagrelor—Pruritus—Bleomycin—testicular cancer	0.000653	0.00183	CcSEcCtD
Ticagrelor—Feeling abnormal—Ifosfamide—testicular cancer	0.00065	0.00182	CcSEcCtD
Ticagrelor—Chest pain—Etoposide—testicular cancer	0.000649	0.00182	CcSEcCtD
Ticagrelor—Nausea—Vinblastine—testicular cancer	0.000649	0.00182	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000645	0.00181	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000645	0.00181	CcSEcCtD
Ticagrelor—Breast disorder—Epirubicin—testicular cancer	0.000642	0.0018	CcSEcCtD
Ticagrelor—Hypotension—Cisplatin—testicular cancer	0.000635	0.00178	CcSEcCtD
Ticagrelor—Hypersensitivity—Dactinomycin—testicular cancer	0.000634	0.00177	CcSEcCtD
Ticagrelor—Gastritis—Epirubicin—testicular cancer	0.000628	0.00176	CcSEcCtD
Ticagrelor—Confusional state—Etoposide—testicular cancer	0.000628	0.00176	CcSEcCtD
Ticagrelor—Abdominal pain—Ifosfamide—testicular cancer	0.000623	0.00175	CcSEcCtD
Ticagrelor—Body temperature increased—Ifosfamide—testicular cancer	0.000623	0.00175	CcSEcCtD
Ticagrelor—Asthenia—Dactinomycin—testicular cancer	0.000617	0.00173	CcSEcCtD
Ticagrelor—Blood creatinine increased—Doxorubicin—testicular cancer	0.000616	0.00172	CcSEcCtD
Ticagrelor—Paraesthesia—Cisplatin—testicular cancer	0.00061	0.00171	CcSEcCtD
Ticagrelor—Dyspnoea—Cisplatin—testicular cancer	0.000606	0.0017	CcSEcCtD
Ticagrelor—Skin disorder—Etoposide—testicular cancer	0.000605	0.00169	CcSEcCtD
Ticagrelor—Breast disorder—Doxorubicin—testicular cancer	0.000594	0.00166	CcSEcCtD
Ticagrelor—Diarrhoea—Dactinomycin—testicular cancer	0.000589	0.00165	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000587	0.00164	CcSEcCtD
Ticagrelor—Vomiting—Bleomycin—testicular cancer	0.000586	0.00164	CcSEcCtD
Ticagrelor—Hypotension—Etoposide—testicular cancer	0.000582	0.00163	CcSEcCtD
Ticagrelor—Rash—Bleomycin—testicular cancer	0.000582	0.00163	CcSEcCtD
Ticagrelor—Gastritis—Doxorubicin—testicular cancer	0.000581	0.00163	CcSEcCtD
Ticagrelor—Dermatitis—Bleomycin—testicular cancer	0.000581	0.00163	CcSEcCtD
Ticagrelor—Hypersensitivity—Ifosfamide—testicular cancer	0.000581	0.00163	CcSEcCtD
Ticagrelor—Asthenia—Ifosfamide—testicular cancer	0.000566	0.00158	CcSEcCtD
Ticagrelor—Feeling abnormal—Cisplatin—testicular cancer	0.00056	0.00157	CcSEcCtD
Ticagrelor—Paraesthesia—Etoposide—testicular cancer	0.000559	0.00157	CcSEcCtD
Ticagrelor—Pruritus—Ifosfamide—testicular cancer	0.000558	0.00156	CcSEcCtD
Ticagrelor—Haematuria—Methotrexate—testicular cancer	0.000558	0.00156	CcSEcCtD
Ticagrelor—Dyspnoea—Etoposide—testicular cancer	0.000555	0.00155	CcSEcCtD
Ticagrelor—Epistaxis—Methotrexate—testicular cancer	0.000552	0.00154	CcSEcCtD
Ticagrelor—Nausea—Bleomycin—testicular cancer	0.000548	0.00153	CcSEcCtD
Ticagrelor—Vomiting—Dactinomycin—testicular cancer	0.000547	0.00153	CcSEcCtD
Ticagrelor—Rash—Dactinomycin—testicular cancer	0.000542	0.00152	CcSEcCtD
Ticagrelor—Diarrhoea—Ifosfamide—testicular cancer	0.000539	0.00151	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Etoposide—testicular cancer	0.000538	0.00151	CcSEcCtD
Ticagrelor—Body temperature increased—Cisplatin—testicular cancer	0.000537	0.0015	CcSEcCtD
Ticagrelor—Fatigue—Etoposide—testicular cancer	0.000537	0.0015	CcSEcCtD
Ticagrelor—Constipation—Etoposide—testicular cancer	0.000532	0.00149	CcSEcCtD
Ticagrelor—Haemoglobin—Methotrexate—testicular cancer	0.000528	0.00148	CcSEcCtD
Ticagrelor—Haemorrhage—Methotrexate—testicular cancer	0.000525	0.00147	CcSEcCtD
Ticagrelor—Haematuria—Epirubicin—testicular cancer	0.000522	0.00146	CcSEcCtD
Ticagrelor—Dizziness—Ifosfamide—testicular cancer	0.000521	0.00146	CcSEcCtD
Ticagrelor—Urinary tract disorder—Methotrexate—testicular cancer	0.000518	0.00145	CcSEcCtD
Ticagrelor—Epistaxis—Epirubicin—testicular cancer	0.000516	0.00145	CcSEcCtD
Ticagrelor—Urethral disorder—Methotrexate—testicular cancer	0.000515	0.00144	CcSEcCtD
Ticagrelor—Feeling abnormal—Etoposide—testicular cancer	0.000513	0.00144	CcSEcCtD
Ticagrelor—Nausea—Dactinomycin—testicular cancer	0.000511	0.00143	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Etoposide—testicular cancer	0.000509	0.00143	CcSEcCtD
Ticagrelor—Vomiting—Ifosfamide—testicular cancer	0.000501	0.0014	CcSEcCtD
Ticagrelor—Hypersensitivity—Cisplatin—testicular cancer	0.000501	0.0014	CcSEcCtD
Ticagrelor—Bradycardia—Epirubicin—testicular cancer	0.0005	0.0014	CcSEcCtD
Ticagrelor—Rash—Ifosfamide—testicular cancer	0.000497	0.00139	CcSEcCtD
Ticagrelor—Dermatitis—Ifosfamide—testicular cancer	0.000497	0.00139	CcSEcCtD
Ticagrelor—Haemoglobin—Epirubicin—testicular cancer	0.000494	0.00138	CcSEcCtD
Ticagrelor—Abdominal pain—Etoposide—testicular cancer	0.000492	0.00138	CcSEcCtD
Ticagrelor—Body temperature increased—Etoposide—testicular cancer	0.000492	0.00138	CcSEcCtD
Ticagrelor—Haemorrhage—Epirubicin—testicular cancer	0.000491	0.00138	CcSEcCtD
Ticagrelor—Eye disorder—Methotrexate—testicular cancer	0.000491	0.00137	CcSEcCtD
Ticagrelor—Asthenia—Cisplatin—testicular cancer	0.000488	0.00137	CcSEcCtD
Ticagrelor—Cardiac disorder—Methotrexate—testicular cancer	0.000487	0.00136	CcSEcCtD
Ticagrelor—Urinary tract disorder—Epirubicin—testicular cancer	0.000485	0.00136	CcSEcCtD
Ticagrelor—Oedema peripheral—Epirubicin—testicular cancer	0.000484	0.00136	CcSEcCtD
Ticagrelor—Haematuria—Doxorubicin—testicular cancer	0.000483	0.00135	CcSEcCtD
Ticagrelor—Connective tissue disorder—Epirubicin—testicular cancer	0.000483	0.00135	CcSEcCtD
Ticagrelor—Urethral disorder—Epirubicin—testicular cancer	0.000482	0.00135	CcSEcCtD
Ticagrelor—Epistaxis—Doxorubicin—testicular cancer	0.000478	0.00134	CcSEcCtD
Ticagrelor—Angiopathy—Methotrexate—testicular cancer	0.000476	0.00133	CcSEcCtD
Ticagrelor—Immune system disorder—Methotrexate—testicular cancer	0.000474	0.00133	CcSEcCtD
Ticagrelor—Mediastinal disorder—Methotrexate—testicular cancer	0.000473	0.00132	CcSEcCtD
Ticagrelor—Nausea—Ifosfamide—testicular cancer	0.000468	0.00131	CcSEcCtD
Ticagrelor—Diarrhoea—Cisplatin—testicular cancer	0.000465	0.0013	CcSEcCtD
Ticagrelor—Bradycardia—Doxorubicin—testicular cancer	0.000463	0.0013	CcSEcCtD
Ticagrelor—Mental disorder—Methotrexate—testicular cancer	0.00046	0.00129	CcSEcCtD
Ticagrelor—Eye disorder—Epirubicin—testicular cancer	0.000459	0.00129	CcSEcCtD
Ticagrelor—Hypersensitivity—Etoposide—testicular cancer	0.000459	0.00128	CcSEcCtD
Ticagrelor—Malnutrition—Methotrexate—testicular cancer	0.000457	0.00128	CcSEcCtD
Ticagrelor—Haemoglobin—Doxorubicin—testicular cancer	0.000457	0.00128	CcSEcCtD
Ticagrelor—Cardiac disorder—Epirubicin—testicular cancer	0.000456	0.00128	CcSEcCtD
Ticagrelor—Haemorrhage—Doxorubicin—testicular cancer	0.000455	0.00127	CcSEcCtD
Ticagrelor—Urinary tract disorder—Doxorubicin—testicular cancer	0.000449	0.00126	CcSEcCtD
Ticagrelor—Oedema peripheral—Doxorubicin—testicular cancer	0.000448	0.00125	CcSEcCtD
Ticagrelor—Asthenia—Etoposide—testicular cancer	0.000447	0.00125	CcSEcCtD
Ticagrelor—Connective tissue disorder—Doxorubicin—testicular cancer	0.000447	0.00125	CcSEcCtD
Ticagrelor—Angiopathy—Epirubicin—testicular cancer	0.000446	0.00125	CcSEcCtD
Ticagrelor—Urethral disorder—Doxorubicin—testicular cancer	0.000446	0.00125	CcSEcCtD
Ticagrelor—Immune system disorder—Epirubicin—testicular cancer	0.000444	0.00124	CcSEcCtD
Ticagrelor—Mediastinal disorder—Epirubicin—testicular cancer	0.000443	0.00124	CcSEcCtD
Ticagrelor—Back pain—Methotrexate—testicular cancer	0.000442	0.00124	CcSEcCtD
Ticagrelor—Pruritus—Etoposide—testicular cancer	0.00044	0.00123	CcSEcCtD
Ticagrelor—Vomiting—Cisplatin—testicular cancer	0.000432	0.00121	CcSEcCtD
Ticagrelor—Mental disorder—Epirubicin—testicular cancer	0.00043	0.00121	CcSEcCtD
Ticagrelor—Rash—Cisplatin—testicular cancer	0.000428	0.0012	CcSEcCtD
Ticagrelor—Dermatitis—Cisplatin—testicular cancer	0.000428	0.0012	CcSEcCtD
Ticagrelor—Malnutrition—Epirubicin—testicular cancer	0.000428	0.0012	CcSEcCtD
Ticagrelor—Diarrhoea—Etoposide—testicular cancer	0.000426	0.00119	CcSEcCtD
Ticagrelor—Eye disorder—Doxorubicin—testicular cancer	0.000425	0.00119	CcSEcCtD
Ticagrelor—Cardiac disorder—Doxorubicin—testicular cancer	0.000422	0.00118	CcSEcCtD
Ticagrelor—Back pain—Epirubicin—testicular cancer	0.000414	0.00116	CcSEcCtD
Ticagrelor—Angiopathy—Doxorubicin—testicular cancer	0.000412	0.00115	CcSEcCtD
Ticagrelor—Dizziness—Etoposide—testicular cancer	0.000412	0.00115	CcSEcCtD
Ticagrelor—Immune system disorder—Doxorubicin—testicular cancer	0.000411	0.00115	CcSEcCtD
Ticagrelor—Vertigo—Methotrexate—testicular cancer	0.000411	0.00115	CcSEcCtD
Ticagrelor—Mediastinal disorder—Doxorubicin—testicular cancer	0.00041	0.00115	CcSEcCtD
Ticagrelor—Nausea—Cisplatin—testicular cancer	0.000404	0.00113	CcSEcCtD
Ticagrelor—Cough—Methotrexate—testicular cancer	0.000399	0.00112	CcSEcCtD
Ticagrelor—Mental disorder—Doxorubicin—testicular cancer	0.000398	0.00112	CcSEcCtD
Ticagrelor—Vomiting—Etoposide—testicular cancer	0.000396	0.00111	CcSEcCtD
Ticagrelor—Malnutrition—Doxorubicin—testicular cancer	0.000396	0.00111	CcSEcCtD
Ticagrelor—Rash—Etoposide—testicular cancer	0.000393	0.0011	CcSEcCtD
Ticagrelor—Dermatitis—Etoposide—testicular cancer	0.000392	0.0011	CcSEcCtD
Ticagrelor—Headache—Etoposide—testicular cancer	0.00039	0.00109	CcSEcCtD
Ticagrelor—Chest pain—Methotrexate—testicular cancer	0.000389	0.00109	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000386	0.00108	CcSEcCtD
Ticagrelor—Vertigo—Epirubicin—testicular cancer	0.000384	0.00108	CcSEcCtD
Ticagrelor—Syncope—Epirubicin—testicular cancer	0.000383	0.00107	CcSEcCtD
Ticagrelor—Back pain—Doxorubicin—testicular cancer	0.000383	0.00107	CcSEcCtD
Ticagrelor—Confusional state—Methotrexate—testicular cancer	0.000376	0.00105	CcSEcCtD
Ticagrelor—Loss of consciousness—Epirubicin—testicular cancer	0.000376	0.00105	CcSEcCtD
Ticagrelor—Cough—Epirubicin—testicular cancer	0.000373	0.00104	CcSEcCtD
Ticagrelor—Nausea—Etoposide—testicular cancer	0.00037	0.00104	CcSEcCtD
Ticagrelor—Hypertension—Epirubicin—testicular cancer	0.000369	0.00103	CcSEcCtD
Ticagrelor—Nervous system disorder—Methotrexate—testicular cancer	0.000366	0.00102	CcSEcCtD
Ticagrelor—Chest pain—Epirubicin—testicular cancer	0.000364	0.00102	CcSEcCtD
Ticagrelor—Skin disorder—Methotrexate—testicular cancer	0.000362	0.00101	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000362	0.00101	CcSEcCtD
Ticagrelor—Vertigo—Doxorubicin—testicular cancer	0.000355	0.000995	CcSEcCtD
Ticagrelor—Syncope—Doxorubicin—testicular cancer	0.000355	0.000994	CcSEcCtD
Ticagrelor—Confusional state—Epirubicin—testicular cancer	0.000352	0.000985	CcSEcCtD
Ticagrelor—Hypotension—Methotrexate—testicular cancer	0.000348	0.000976	CcSEcCtD
Ticagrelor—Loss of consciousness—Doxorubicin—testicular cancer	0.000348	0.000974	CcSEcCtD
Ticagrelor—Cough—Doxorubicin—testicular cancer	0.000345	0.000967	CcSEcCtD
Ticagrelor—Shock—Epirubicin—testicular cancer	0.000343	0.000962	CcSEcCtD
Ticagrelor—Nervous system disorder—Epirubicin—testicular cancer	0.000342	0.000958	CcSEcCtD
Ticagrelor—Hypertension—Doxorubicin—testicular cancer	0.000342	0.000957	CcSEcCtD
Ticagrelor—Skin disorder—Epirubicin—testicular cancer	0.000339	0.000949	CcSEcCtD
Ticagrelor—Chest pain—Doxorubicin—testicular cancer	0.000337	0.000943	CcSEcCtD
Ticagrelor—Paraesthesia—Methotrexate—testicular cancer	0.000335	0.000938	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000335	0.000937	CcSEcCtD
Ticagrelor—Dyspnoea—Methotrexate—testicular cancer	0.000332	0.000931	CcSEcCtD
Ticagrelor—Dyspepsia—Methotrexate—testicular cancer	0.000328	0.000919	CcSEcCtD
Ticagrelor—Hypotension—Epirubicin—testicular cancer	0.000326	0.000913	CcSEcCtD
Ticagrelor—Confusional state—Doxorubicin—testicular cancer	0.000326	0.000912	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000322	0.000902	CcSEcCtD
Ticagrelor—Fatigue—Methotrexate—testicular cancer	0.000322	0.0009	CcSEcCtD
Ticagrelor—Shock—Doxorubicin—testicular cancer	0.000318	0.00089	CcSEcCtD
Ticagrelor—Nervous system disorder—Doxorubicin—testicular cancer	0.000317	0.000887	CcSEcCtD
Ticagrelor—Skin disorder—Doxorubicin—testicular cancer	0.000314	0.000878	CcSEcCtD
Ticagrelor—Paraesthesia—Epirubicin—testicular cancer	0.000313	0.000878	CcSEcCtD
Ticagrelor—Dyspnoea—Epirubicin—testicular cancer	0.000311	0.000871	CcSEcCtD
Ticagrelor—Feeling abnormal—Methotrexate—testicular cancer	0.000307	0.000861	CcSEcCtD
Ticagrelor—Dyspepsia—Epirubicin—testicular cancer	0.000307	0.00086	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Methotrexate—testicular cancer	0.000305	0.000854	CcSEcCtD
Ticagrelor—Hypotension—Doxorubicin—testicular cancer	0.000302	0.000845	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000301	0.000844	CcSEcCtD
Ticagrelor—Fatigue—Epirubicin—testicular cancer	0.000301	0.000843	CcSEcCtD
Ticagrelor—Constipation—Epirubicin—testicular cancer	0.000298	0.000836	CcSEcCtD
Ticagrelor—Abdominal pain—Methotrexate—testicular cancer	0.000295	0.000826	CcSEcCtD
Ticagrelor—Body temperature increased—Methotrexate—testicular cancer	0.000295	0.000826	CcSEcCtD
Ticagrelor—Paraesthesia—Doxorubicin—testicular cancer	0.00029	0.000812	CcSEcCtD
Ticagrelor—Dyspnoea—Doxorubicin—testicular cancer	0.000288	0.000806	CcSEcCtD
Ticagrelor—Feeling abnormal—Epirubicin—testicular cancer	0.000288	0.000805	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Epirubicin—testicular cancer	0.000285	0.000799	CcSEcCtD
Ticagrelor—Dyspepsia—Doxorubicin—testicular cancer	0.000284	0.000796	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000279	0.000781	CcSEcCtD
Ticagrelor—Fatigue—Doxorubicin—testicular cancer	0.000278	0.00078	CcSEcCtD
Ticagrelor—Constipation—Doxorubicin—testicular cancer	0.000276	0.000773	CcSEcCtD
Ticagrelor—Body temperature increased—Epirubicin—testicular cancer	0.000276	0.000773	CcSEcCtD
Ticagrelor—Abdominal pain—Epirubicin—testicular cancer	0.000276	0.000773	CcSEcCtD
Ticagrelor—Hypersensitivity—Methotrexate—testicular cancer	0.000275	0.000769	CcSEcCtD
Ticagrelor—Asthenia—Methotrexate—testicular cancer	0.000268	0.000749	CcSEcCtD
Ticagrelor—Feeling abnormal—Doxorubicin—testicular cancer	0.000266	0.000745	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000264	0.000739	CcSEcCtD
Ticagrelor—Pruritus—Methotrexate—testicular cancer	0.000264	0.000739	CcSEcCtD
Ticagrelor—Hypersensitivity—Epirubicin—testicular cancer	0.000257	0.00072	CcSEcCtD
Ticagrelor—Abdominal pain—Doxorubicin—testicular cancer	0.000255	0.000715	CcSEcCtD
Ticagrelor—Body temperature increased—Doxorubicin—testicular cancer	0.000255	0.000715	CcSEcCtD
Ticagrelor—Diarrhoea—Methotrexate—testicular cancer	0.000255	0.000715	CcSEcCtD
Ticagrelor—Asthenia—Epirubicin—testicular cancer	0.00025	0.000701	CcSEcCtD
Ticagrelor—Pruritus—Epirubicin—testicular cancer	0.000247	0.000691	CcSEcCtD
Ticagrelor—Dizziness—Methotrexate—testicular cancer	0.000247	0.000691	CcSEcCtD
Ticagrelor—Diarrhoea—Epirubicin—testicular cancer	0.000239	0.000669	CcSEcCtD
Ticagrelor—Hypersensitivity—Doxorubicin—testicular cancer	0.000238	0.000666	CcSEcCtD
Ticagrelor—Vomiting—Methotrexate—testicular cancer	0.000237	0.000664	CcSEcCtD
Ticagrelor—Rash—Methotrexate—testicular cancer	0.000235	0.000658	CcSEcCtD
Ticagrelor—Dermatitis—Methotrexate—testicular cancer	0.000235	0.000658	CcSEcCtD
Ticagrelor—Headache—Methotrexate—testicular cancer	0.000234	0.000654	CcSEcCtD
Ticagrelor—Asthenia—Doxorubicin—testicular cancer	0.000232	0.000649	CcSEcCtD
Ticagrelor—Dizziness—Epirubicin—testicular cancer	0.000231	0.000646	CcSEcCtD
Ticagrelor—Pruritus—Doxorubicin—testicular cancer	0.000228	0.00064	CcSEcCtD
Ticagrelor—Vomiting—Epirubicin—testicular cancer	0.000222	0.000621	CcSEcCtD
Ticagrelor—Nausea—Methotrexate—testicular cancer	0.000222	0.00062	CcSEcCtD
Ticagrelor—Diarrhoea—Doxorubicin—testicular cancer	0.000221	0.000619	CcSEcCtD
Ticagrelor—Rash—Epirubicin—testicular cancer	0.00022	0.000616	CcSEcCtD
Ticagrelor—Dermatitis—Epirubicin—testicular cancer	0.00022	0.000616	CcSEcCtD
Ticagrelor—Headache—Epirubicin—testicular cancer	0.000219	0.000612	CcSEcCtD
Ticagrelor—Dizziness—Doxorubicin—testicular cancer	0.000214	0.000598	CcSEcCtD
Ticagrelor—Nausea—Epirubicin—testicular cancer	0.000207	0.000581	CcSEcCtD
Ticagrelor—Vomiting—Doxorubicin—testicular cancer	0.000205	0.000575	CcSEcCtD
Ticagrelor—Rash—Doxorubicin—testicular cancer	0.000204	0.00057	CcSEcCtD
Ticagrelor—Dermatitis—Doxorubicin—testicular cancer	0.000203	0.00057	CcSEcCtD
Ticagrelor—Headache—Doxorubicin—testicular cancer	0.000202	0.000566	CcSEcCtD
Ticagrelor—Nausea—Doxorubicin—testicular cancer	0.000192	0.000537	CcSEcCtD
